Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 746531, 11 pages
http://dx.doi.org/10.1155/2014/746531
Research Article

PKCδ Promotes High Glucose Induced Renal Tubular Oxidative Damage via Regulating Activation and Translocation of p66Shc

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410000, China

Received 11 May 2014; Revised 30 July 2014; Accepted 10 August 2014; Published 13 October 2014

Academic Editor: Antonio Ayala

Copyright © 2014 Panai Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. S. Kanwar, L. Sun, P. Xie, F.-Y. Liu, and S. Chen, “A glimpse of various pathogenetic mechanisms of diabetic nephropathy,” Annual Review of Pathology: Mechanisms of Disease, vol. 6, pp. 395–423, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. C. Stanton, “Clinical challenges in diagnosis and management of diabetic kidney disease,” American Journal of Kidney Diseases, vol. 63, supplement 2, no. 2, pp. S3–S21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. J. Lau, N. Godin, H. Maachi et al., “Bcl-2-modifying factor induces renal proximal tubular cell apoptosis in diabetic mice,” Diabetes, vol. 61, no. 2, pp. 474–484, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Velagapudi, B. S. Bhandari, S. Abboud-Werner, S. Simone, H. E. Abboud, and S. L. Habib, “The tuberin/mTOR pathway promotes apoptosis of tubular epithelial cells in diabetes,” Journal of the American Society of Nephrology, vol. 22, no. 2, pp. 262–273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M.-L. Brezniceanu, C. J. Lau, N. Godin et al., “Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 21, no. 6, pp. 943–954, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Morcos, A. A. R. Sayed, A. Bierhaus et al., “Activation of tubular epithelial cells in diabetic nephropathy,” Diabetes, vol. 51, no. 12, pp. 3532–3544, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. R. E. Gilbert and M. E. Cooper, “The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?” Kidney International, vol. 56, no. 5, pp. 1627–1637, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Giorgio, E. Migliaccio, F. Orsini et al., “Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis,” Cell, vol. 122, no. 2, pp. 221–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Hall and R. J. Unwin, “The not so “mighty chondrion”: emergence of renal diseases due to mitochondrial dysfunction,” Nephron Physiology, vol. 105, no. 1, pp. 1–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Migliaccio, M. Giogio, S. Mele et al., “The p66shc adaptor protein controls oxidative stress response and life span in mammals,” Nature, vol. 402, no. 6759, pp. 309–313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Arany, A. Faisal, J. S. Clark, T. Vera, R. Baliga, and Y. Nagamine, “p66SHC-mediated mitochondrial dysfunction in renal proximal tubule cells during oxidative injury,” The American Journal of Physiology—Renal Physiology, vol. 298, no. 5, pp. F1214–F1221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Sun, L. Xiao, J. Nie et al., “p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway,” The American Journal of Physiology—Renal Physiology, vol. 299, no. 5, pp. F1014–F1025, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Arany, A. Faisal, Y. Nagamine, and R. L. Safirstein, “p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells,” The Journal of Biological Chemistry, vol. 283, no. 10, pp. 6110–6117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Pinton, A. Rimessi, S. Marchi et al., “Protein kinase C β and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc,” Science, vol. 315, no. 5812, pp. 659–663, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. U. Kikkawa, H. Matsuzaki, and T. Yamamoto, “Protein kinase Cδ (PKCδ): activation mechanisms and functions,” Journal of Biochemistry, vol. 132, no. 6, pp. 831–839, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. D. Persaud, V. Hoang, J. Huang, and A. Basu, “Involvement of proteolytic activation of PKCδ in cisplatin-induced apoptosis in human small cell lung cancer H69 cells,” International Journal of Oncology, vol. 27, no. 1, pp. 149–154, 2005. View at Google Scholar · View at Scopus
  17. X. Qi, M. H. Disatnik, N. Shen, R. A. Sobel, and D. Mochly-Rosen, “Aberrant mitochondrial fission in neurons induced by protein kinase Cδ under oxidative stress conditions in vivo,” Molecular Biology of the Cell, vol. 22, no. 2, pp. 256–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Wang, L. Xiao, and M. G. Kazanietz, “p23/Tmp21 associates with protein kinase Cδ (PKCδ) and modulates its apoptotic function,” The Journal of Biological Chemistry, vol. 286, no. 18, pp. 15821–15831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Morita, H. Matsuzaki, T. Yamamoto, Y. Fukami, and U. Kikkawa, “Epidermal growth factor receptor phosphorylates protein kinase C δ at Tyr332 to form a trimeric complex with p66Shc in the H2O2-stimulated cells,” The Journal of Biochemistry, vol. 143, no. 1, pp. 31–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Haruna, N. Kashihara, M. Satoh et al., “Amelioration of progressive renal injury by genetic manipulation of Klotho gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2331–2336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Sun, D. Zhang, F. Liu et al., “Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192,” Journal of Pathology, vol. 225, no. 3, pp. 364–377, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Sun, S. Shukair, T. J. Naik, F. Moazed, and H. Ardehali, “Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II,” Molecular and Cellular Biology, vol. 28, no. 3, pp. 1007–1017, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Li, N. Pabla, Q. Wei et al., “PKC-δ promotes renal tubular cell apoptosis associated with proteinuria,” Journal of the American Society of Nephrology, vol. 21, no. 7, pp. 1115–1124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Verzola, M. T. Gandolfo, F. Ferrario et al., “Apoptosis in the kidneys of patients with type II diabetic nephropathy,” Kidney International, vol. 72, no. 10, pp. 1262–1272, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. G. G. Camici, M. Schiavoni, P. Francia et al., “Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 12, pp. 5217–5222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. A. Tomilov, V. Bicocca, R. A. Schoenfeld et al., “Decreased superoxide production in macrophages of long-lived p66Shc knock-out mice,” Journal of Biological Chemistry, vol. 285, no. 2, pp. 1153–1165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Vashistha and L. Meggs, “Diabetic nephropathy: lessons from the mouse,” Ochsner Journal, vol. 13, no. 1, pp. 140–146, 2013. View at Google Scholar · View at Scopus
  28. S. C. Ranieri, S. Fusco, E. Panieri et al., “Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 30, pp. 13420–13425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Paneni, P. Mocharla, A. Akhmedov et al., “Gene silencing of the mitochondrial adaptor p66Shc suppresses vascular hyperglycemic memory in diabetes,” Circulation Research, vol. 111, no. 3, pp. 278–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Shi, F. Cosentino, G. G. Camici et al., “Oxidized low-density lipoprotein activates p66shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase c-β, and c-jun n-terminal kinase kinase in human endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 9, pp. 2090–2097, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Chen, G. Wang, X. Zhai et al., “Selective inhibition of protein kinase Cβ2 attenuates the adaptor P66Shc-mediated intestinal ischemia-reperfusion injury,” Cell Death and Disease, vol. 5, no. 4, Article ID e1164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Liu, Q. Yuan, S. Zhao et al., “High glucose induces apoptosis in embryonic neural progenitor cells by a pathway involving protein PKCδ,” Cellular Signalling, vol. 23, no. 8, pp. 1366–1374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Acin-Perez, B. Hoyos, J. Gong et al., “Regulation of intermediary metabolism by the PKCδ signalosome in mitochondria,” The FASEB Journal, vol. 24, no. 12, pp. 5033–5042, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. P. Davies, H. Reddy, M. Caivano, and P. Cohen, “Specificity and mechanism of action of some commonly used protein kinase inhibitors,” Biochemical Journal, vol. 351, no. 1, pp. 95–105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. C. S. Lin, F. Y. Lin, L. J. Ho et al., “PKCδ signalling regulates SR-A and CD36 expression and foam cell formation,” Cardiovascular Research, vol. 95, no. 3, pp. 346–355, 2012. View at Publisher · View at Google Scholar
  36. I. Talior, T. Tennenbaum, T. Kuroki, and H. Eldar-Finkelman, “PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 2, pp. E405–E411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Leitges, M. Mayr, U. Braun et al., “Exacerbated vein graft arteriosclerosis in protein kinase Cδ-null mice,” The Journal of Clinical Investigation, vol. 108, no. 10, pp. 1505–1512, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. C. L. Murriel, E. Churchill, K. Inagaki, L. I. Szweda, and D. Mochly-Rosen, “Protein kinase Cδ activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving bad and the mitochondria,” The Journal of Biological Chemistry, vol. 279, no. 46, pp. 47985–47991, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. E. N. Churchill and L. I. Szweda, “Translocation of δPKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function,” Archives of Biochemistry and Biophysics, vol. 439, no. 2, pp. 194–199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Leitges, K. Gimborn, W. Elis et al., “Protein kinase C-δ is a negative regulator of antigen-induced mast cell degranulation,” Molecular and Cellular Biology, vol. 22, no. 12, pp. 3970–3980, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Mochly-Rosen, K. Das, and K. V. Grimes, “Protein kinase C, an elusive therapeutic target?” Nature Reviews Drug Discovery, vol. 11, no. 12, pp. 937–957, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. L. P. Aiello, L. Vignati, M. J. Sheetz et al., “Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the protein kinase c β inhibitor-diabetic retinopathy study and the protein kinase c β inhibitor-diabetic retinopathy study 2,” Retina, vol. 31, no. 10, pp. 2084–2094, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. K. R. Tuttle, J. B. McGill, D. J. Haney, T. E. Lin, and P. W. Anderson, “Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 4, pp. 631–636, 2007. View at Publisher · View at Google Scholar · View at Scopus